American Well Corporation AMWL, popularly known as Amwell, has expanded its clinical programs portfolio by partnering with Hello Heart, a digital leader in preventive heart health. Hello Heart offers the first app and connected heart monitor to help users track and manage their heart health with real-time tips.

Now available on the Amwell Converge platform, Hello Heart provides eligible members with tools to monitor and manage heart health risks such as high blood pressure and cholesterol. This partnership enhances Amwell’s ability to deliver comprehensive virtual care solutions from innovative partners, integrating cardiovascular health with primary care, urgent care, and behavioral health services for its clients' members.

This unified system enables health plans to provide employers and members with easy access to personalized, cost-effective healthcare solutions, aiming to improve clinical outcomes and enhance efficiency. Members who enroll in the digital heart health program receive a connected blood pressure monitor and an app that offers personalized coaching and tracks key health metrics. Clinicians can access the data and provide tailored care recommendations based on the results.

Likely Trend of AMWL Stock Following the News

Following the news, shares of AMWL rose 3.3% to $9.94 at yesterday’s closing.

Shares of Amwell have plunged 66.6% year to date compared with the industry’s 10.2% decline. The S&P 500 has risen 19.6% in the same time frame.

Amwell’s partnership with Hello Heart to expand its portfolio marks a positive development, reflecting optimism for investors. This collaboration enhances Amwell's hybrid care platform with a leading cardiovascular health management solution, reinforcing its comprehensive digital health offerings. With a robust platform already serving over 100 million covered lives, this expansion highlights Amwell’s commitment to addressing key health issues and improving care quality, potentially driving positive price performance and investor confidence.

Image Source: Zacks Investment Research

Significance of Amwell’s Partnership With Hello Heart

The addition of Hello Heart to Amwell’s clinical programs is a pivotal step in addressing the growing heart disease crisis, the leading cause of death in the United States.

By offering this solution, Amwell enables health plans and employers to tackle cardiovascular risks at scale, providing members with real-time heart health monitoring and personalized coaching. This partnership not only targets improved health outcomes but also helps reduce the significant financial burden of heart disease, which averages $12,500 per member annually. Amwell’s expansion into heart health through Hello Heart is a strategic move to provide cost-effective, whole-person care solutions.